UNSPSC 51384515: Oxaprozin

This classification denotes a cyclooxygenase inhibitor with the molecular formula C18H15NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MHJ80W9LRB, chemically known as 4,5-diphenyl-2-oxazolepropionic acid but generally known as oxaprozin, which bears US NIH Compound Identifier 4614. European Medicines Agency schedules Oxaprozin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09502MIG.

UNSPSC 51384515 Oxaprozin is a Commodity code for a nonsteroidal anti-inflammatory drug (NSAID). However, the most recent state and local procurement activity tagged to this code involves naloxone and drug deactivation systems—pharmaceutical and medical supplies that fall outside oxaprozin's therapeutic class and typical procurement scope. The mismatch suggests either a misclassification in the opportunity tagging or minimal recent activity authentically aligned with oxaprozin procurement at the state and local level.

The single recent opportunity on record is Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The response deadline was July 26, 2023—a timestamp inconsistent with the posting date—suggesting data quality issues in the source. The contract includes a two-year initial term with a one-year renewal option, fixed-fee pricing, E-Verify compliance, workers' compensation and liability insurance requirements, and potential FEMA funding with federal environmental compliance obligations. Bidders submit electronically through Seminole County's e-Procurement Portal with all shipping and delivery costs included in proposals. The code shows little recent relevant activity for oxaprozin specifically and does not support a reliable characterization of state and local procurement patterns under this Commodity code.